Log in to save to my catalogue

Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibi...

Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2740827719

Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"

About this item

Full title

Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"

Author / Creator

Publisher

Cham: Springer International Publishing

Journal title

Drug safety, 2022-12, Vol.45 (12), p.1551-1552

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

[6] is used by the World Health Organization Uppsala Monitoring Center (WHO-UMC) [7], and the previous study has shown that it has the most conservative signal detection trend among signal detection methods based on frequentist statistics [8]. Since the original paper [1] does not include detailed data on the number of reports, it was not possible...

Alternative Titles

Full title

Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2740827719

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2740827719

Other Identifiers

ISSN

0114-5916

E-ISSN

1179-1942

DOI

10.1007/s40264-022-01240-w

How to access this item